IRIS

1.5 Abstract in rivista: [2184] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 541 a 560 di 2.184
Titolo Data di pubblicazione Autore(i) File
CHARACTERISTICS OF LAMIVUDINE RESISTANCE PROFILES IN HBV REVERSE TRANSCRIPTASE FROM A NATIONAL COLLABORATIVE STUDY OF HIV plus HBV INFECTED INDIVIDUALS ON LONG-EXPOSURE TO LAMIVUDINE INCLUDING REGIMENS 1-gen-2009 Alteri, C; Svicher, V; Cento, V; Gori, C; Salpini, R; Marcuccilli, F; Bertoli, A; Arlotti, M; Puoti, M; Ladisa, N; Rizzardini, G; Andreoni, M; Ceccherini-Silberstein, F; Monforte, Ad; Perno, Cf
Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy 1-gen-2017 Di Maio, Vc; Barbaliscia, S; Teti, E; Lenci, I; Aragri, M; Polilli, E; Gianserra, L; Palitti, Vp; Bruzzone, B; Paolucci, S; Coppola, N; Ruggiero, T; Pollicino, T; Niero, F; Micheli, V; Di Biagio, A; Bertoli, A; Sticchi, L; Maida, I; Francioso, S; Foroghi, L; Calvaruso, V; Morisco, F; Lleo, A; Ciancio, A; Maserati, R; Brancaccio, G; Puoti, M; Toniutto, P; Vullo, V; Aghemo, A; Cariti, G; Bonora, S; Babudieri, S; Gubertini, Ga; Rendina, M; Pellicelli, Am; Sangiovanni, V; Ciaccio, A; Taliani, G; Raimondo, G; Craxi, A; Pasquazzi, C; Sarmati, L; Parruti, G; Angelico, M; Andreoni, M; Cento, V; Perno, Cf; Ceccherini-Silberstein, F
SLOW HCV KINETICS FOLLOWING SOFOSBUVIR plus RIBAVIRIN ADMINISTRATION IN REAL-LIFE SETTING OF LIVER TRANSPLANT RECIPIENTS WITH SEVERE RECURRENT HEPATITIS C 1-gen-2015 Cento, V; Donato, Mf; Lenci, I; Rendina, M; Milana, M; Di Maio, Vc; Monico, S; Aragri, M; Alfieri, R; Abedrabbo, A; Sforza, D; Manuelli, M; Mameli, L; Sorbo, Mc; Canu, R; Ponti, Ml; Chiala, C; Malinverno, F; Marenco, S; Milanesi, L; Picciotto, A; Rossi, G; Di Leo, A; Tisone, G; Zamboni, F; Ganga, R; Colombo, M; Perno, Cf; Angelico, M; Ceccherini-Silberstein, F
HCV KINETICS AND QUASISPECIES EVOLUTION WITHIN THE FIRST HOURS OF TELAPREVIR-BASED TRIPLE THERAPY IN PREVIOUSLY TREATED HCV-PATIENTS 1-gen-2013 Cento, V; De Luca, F; Valenti, F; Tontodonati, M; Di Maio, Vc; Bellocchi, Mc; Armenia, D; Carioti, L; Trave, F; Cacciatore, P; Madeddu, G; Bertoli, A; Angelico, M; Babudieri, S; Parruti, G; Ceccherini-Silberstein, F; Perno, Cf
KEY GENETIC SIGNATURES IN THE WHOLE pre-S1/Pre-S2/S GENE CORRELATE WITH HBV-INDUCED CARCINOGENESIS BY AFFECTING HBsAg SECRETION AND RELEASE 1-gen-2013 Svicher, V; Neumann-Fraune, M; Mirabelli, C; Salpini, R; Cento, V; Di Maio, Vc; Bertoli, A; Alteri, C; Aragri, M; Gori, C; Micheli, V; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrecchia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf
Natural NS3, NS5A and NS5B HCV resistance is common in real practice, differently associated to HCV genotypes and response to NS5A inhibitors 1-gen-2016 Cento, V; Sorbo, Mc; Bertoli, A; Lenci, I; Polilli, E; Masetti, C; Gianserra, L; Teti, E; Biliotti, E; Magni, Cf; Aragri, M; Micheli, V; Melis, M; Nicolini, La; Marenco, S; Calvaruso, V; Paolucci, S; Baldanti, F; Morisco, F; Siciliano, M; Palitti, Vp; Andreone, P; Bruzzone, B; Coppola, N; Ruggiero, T; Lichtner, M; Menzaghi, B; Romagnoli, D; Iapadre, N; Di Maio, Vc; De Leonardis, F; Milana, M; Cacciatore, P; Pieri, A; Sarmati, L; Landonio, S; Gasbarrini, A; Puoti, M; Craxi, A; Vullo, V; Pellicelli, Am; Babudieri, S; Rizzardini, G; Taliani, G; Andreoni, M; Pasquazzi, C; Parruti, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
The HBV genetic barrier and the overlapping structure of HBV genome synergistically modulate drug resistance emergence and immune-escape potential of HBV genotypes 1-gen-2010 Svicher, V; Cento, V; Salpini, R; Mercurio, F; Fraune, M; Beggel, B; Han, Y; Gori, C; Wittkop, L; Bertoli, A; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, N; Mazzotta, F; De Sanctis, Gm; Trimulet, P; Angelico, M; Zhang, Xx; Verheyen, J; Ceccherini-Silberstein, F; Perno, Cf
CORRELATION OF EARLY DETECTION OF HCV NS3-RESISTANCE AND VIROLOGICAL FAILURE IN PATIENTS TREATED WITH TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR 1-gen-2013 Cento, V; Di Maio, Vc; Di Paolo, D; De Luca, F; Micheli, V; Tontodonati, M; Bellocchi, Mc; Carioti, L; Armenia, D; De Leonardis, F; Antonucci, Fp; Madeddu, G; Magni, C; Sarrecchia, C; Babudieri, S; Parruti, G; Angelico, M; Rizzardini, G; Perno, Cf; Ceccherini-Silberstein, F
BIPHASIC KINETICS OF HCV-RNA DECAY IS ACCOMPANIED BY AN EVEN FASTER AMINOTRANSFERASES NORMALIZATION IN ALL-DAA TREATED CIRRHOTIC PATIENTS: A DIFFERENT SCENARIO FROM INTERFERON-BASED THERAPIES 1-gen-2016 Cento, V; Di Carlo, D; Nguyen, Tht; Biliotti, E; Pasquazzi, C; Gianserra, L; Di Paolo, D; Calvaruso, V; Teti, E; Cerrone, M; Romagnoli, D; Melis, M; Danieli, E; Menzaghi, B; Polilli, E; Siciliano, M; Nicolini, La; Di Biagio, A; Magni, Cf; Antonucci, Fp; Di Maio, Vc; Alfieri, R; Sarmati, L; Casalino, P; Bernardini, S; Micheli, V; Rizzardini, G; Villa, E; Parruti, G; Quirino, T; Puoti, M; Babudieri, S; Monforte, Ad; Andreoni, M; Craxi, A; Lenci, I; Angelico, M; Taliani, G; Guedj, J; Ceccherini-Silberstein, F; Perno, Cf
NOVEL REVERSE TRANSCRIPTASE MUTATIONS SPECIFICALLY ASSOCIATED WITH SELECTED ANTI-HBV TREATMENT CAN INDUCE ALTERATIONS AND STOP-CODONS IN HBV S ANTIGEN 1-gen-2012 Cento, V; Van Hemert, F; Di Maio, Vc; Salpini, R; Mirabelli, C; Bertoli, A; Gori, C; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; De Sanctis, Gm; Marino, N; Mazzotta, F; Cappiello, G; Sarrecchia, C; Ceccherini-Silberstein, F; Andreoni, M; Angelico, M; Perno, Cf; Svicher, V
KEY PATTERNS OF HBsAg MUTATIONS CORRELATE WITH MECHANISMS UNDERLYING LEVELS OF SERUM HBV DNA 1-gen-2014 Surdo, M; Cortese, Mf; Mirabelli, C; Salpini, R; Zhang, J; Van Hemert, F; Cento, V; Pollicita, M; Gubertini, G; De Sanctis, Gm; Trimoulet, P; Fleury, H; Mazzotta, F; Longo, R; Cappiello, G; Spano, A; Sarrecchia, C; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf; Svicher, V
SPECIFIC HBSAG GENETIC-DETERMINANTS ARE ASSOCIATED WITH OCCULT HBV-INFECTION IN VIVO AND HBSAG-DETECTION 1-gen-2011 Svicher, V; Cento, V; Bernassola, M; Neumann-Fraune, M; Salpini, R; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spano, A; Ceccherini-Silberstein, F; Verhejen, J; Cappiello, G; Perno, Cf
HBV Evolution and Drug Resistance Emergence in HIV-HBV Co-infected Patients depends upon the Synergistic Interaction between Immunological and Pharmacological Selective Pressure 1-gen-2010 Cento, V; Salpini, R; Lo Presti, A; Gori, C; Bertoli, A; Marcuccilli, F; Arlotti, M; Puoti, M; Ladisa, N; Rizzardini, G; Ciccozzi, M; Monforte, Ad; Perno, Cf; Svicher, V
NS3-resistance in advanced HCV patients treated with BOC/TRV-based therapy: impact on virological failure of baseline and early time points 1-gen-2013 Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Bertoli, A; De Leonardis, F; Madeddu, G; Magni, C; Sarrecchia, C; Nosotti, L; Tortora, A; Di Biagio, A; Nicolini, La; Parruti, G; Babudieri, S; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Early detection of NS3-resistance in HCV patients with advanced disease treated with BOC/TVR-based therapy: analysis by population- and ultra-deep sequencing 1-gen-2013 Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Carioti, L; Fortuna, S; Bertoli, A; De Luca, F; De Leonardis, F; Madeddu, G; Navarra, P; Magni, C; Sarrecchia, C; Babudieri, S; Siciliano, M; Parruti, G; Angelico, M; Rizzardini, G; Perno, Cf; Ceccherini-Silberstein, F
Clinical usefulness of HCV sequencing on clinical samples with different HCV-RNA levels 1-gen-2014 Ceccherini-Silberstein, F; Di Maio, Vc; Cento, V; Di Paolo, D; Aragri, M; De Leonardis, F; Tontodonati, M; Micheli, V; Antonucci, Fp; Campoli, R; Mancon, A; Bertoli, A; Lenci, I; Cucchiarelli, S; Manunta, A; Di Biagio, A; Sarrecchia, C; Nicolini, La; Marenco, S; Ciotti, M; Nosotti, L; Gianelli, V; Merli, M; Siciliano, M; Landonio, S; De Maria, A; Pellicelli, A; Vecchiet, J; Magni, C; Babudieri, S; Mura, Ms; Taliani, G; Lichtner, M; Maida, I; Vespasiani, U; Romano, M; Morisco, F; Gasbarrini, A; Mastroianni, C; Puoti, M; Mangia, A; Bruno, S; Tisone, G; Caporaso, N; Picciotto, A; Andreoni, M; Parruti, G; Rizzardini, G; Angelico, M; Perno, Cf
Biphasic kinetics of HCV-RNA decay and quasispecies evolution during DAA-treatment are associated with risk of virological failure 1-gen-2013 Cento, V; Di Maio, Vc; Valenti, F; Tontodonati, M; Armenia, D; Bellocchi, Mc; Carioti, L; Antonucci, Fp; Trave, F; Cacciatore, P; De Luca, F; Manunta, Af; Bertoli, A; Angelico, M; Pizzigallo, E; Babudieri, S; Parruti, G; Ceccherini-Silberstein, F; Perno, Cf
THE LOWEST X4 GENO2PHENO-FALSE POSITIVE RATE IS ASSOCIATED WITH GREATER CD4-DEPLETION 1-gen-2011 Santoro, Mm; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; Ceccherini-Silberstein, F; Perno, Cf
TREATMENT FAILURE TO FIRST-LINE DIRECT ANTIVIRAL (DAA) IN HCV-RELATED ADVANCED LIVER DISEASE: AN ITALIAN REAL-LIFE URBAN SETTING 1-gen-2016 Di Paolo, D; Rossi, P; Lenci, I; Milana, M; Masetti, C; Santopaolo, F; Lionetti, R; D'Offizi, G; Pellicelli, A; Fondacaro, L; Siciliano, M; Gerardi, V; Chiesara, F; Moretti, A; Ceccherini-Silberstein, F; Cento, V; Perno, Cf; Angelico, M
Fast and deep early HCV-RNA decay is accompanied by fast aminotransferases normalization values in cirrhotic HCV-1 patients treated with paritaprevir/r-ombitasvir and dasabuvir with ribavirin: a potential role of baseline major resistance mutations 1-gen-2015 Cento, V; Teti, E; Biliotti, E; Fiore, F; Antonucci, F; Aragri, M; Magni, Cf; Di Paolo, D; Palazzo, D; La Rosa, Ky; De Luca, F; Sorbo, Mc; Di Maio, Vc; Casalino, P; Sarrecchia, C; Lambiase, L; Gianserra, L; Perinelli, P; Sarmati, L; Gubertini, Ga; Angelico, M; Pasquazzi, C; Andreoni, M; Taliani, G; Perno, Cf; Ceccherini-Silberstein, F
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 541 a 560 di 2.184
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista2184
Autore
  • Oyen, Willem Jozef Gerard230
  • GUAZZONI, GIORGIO FERRUCCIO161
  • Scorsetti, Marta128
  • Repici, Alessandro126
  • Armuzzi, Alessandro105
  • Lughezzani, Giovanni104
  • SANTORO, Armando87
  • CHITI, ARTURO86
  • Buffi, Nicolomaria85
  • Mangiavillano, Benedetto83
Data di pubblicazione
  • 2020 - 2026115
  • 2010 - 20191351
  • 2000 - 2009606
  • 1990 - 1999111
  • 1988 - 19891
Editore
  • Nature Publishing Group4
  • s.n4
  • ICRS3
  • Blackwell1
Rivista
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...124
  • EUROPEAN UROLOGY. SUPPLEMENTS124
  • GASTROENTEROLOGY123
  • THE JOURNAL OF UROLOGY111
  • DIGESTIVE AND LIVER DISEASE100
  • THE JOURNAL OF NUCLEAR MEDICINE80
  • ANNALS OF THE RHEUMATIC DISEASES69
  • RADIOTHERAPY AND ONCOLOGY59
  • ANNALS OF ONCOLOGY57
  • JOURNAL OF CLINICAL ONCOLOGY45
Keyword
  • Myelodysplastic syndrome8
  • Survival4
  • biomimetic3
  • Mitochondrial ferritin3
  • osteochondral3
  • Prognosis3
  • scaffold3
  • Sideroblastic anemia3
  • viscosupplementation3
  • COLONOSCOPIC SURVEILLANCE2
Lingua
  • eng817
  • ita28
  • und6
Accesso al fulltext
  • no fulltext2131
  • reserved51
  • open2